company background image
SDMH.F logo

Sartorius Stedim Biotech OTCPK:SDMH.F Stock Report

Last Price

US$288.50

Market Cap

US$28.2b

7D

0.8%

1Y

-10.1%

Updated

26 Mar, 2024

Data

Company Financials +

Sartorius Stedim Biotech S.A.

OTCPK:SDMH.F Stock Report

Market Cap: US$28.2b

SDMH.F Stock Overview

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

SDMH.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health3/6
Dividends0/6

Sartorius Stedim Biotech S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sartorius Stedim Biotech
Historical stock prices
Current Share Price€288.50
52 Week High€321.11
52 Week Low€175.12
Beta0.59
1 Month Change8.66%
3 Month Change8.97%
1 Year Change-10.12%
3 Year Change-28.64%
5 Year Change126.22%
Change since IPO616.77%

Recent News & Updates

Recent updates

Shareholder Returns

SDMH.FUS Life SciencesUS Market
7D0.8%-1.9%0.6%
1Y-10.1%3.9%29.5%

Return vs Industry: SDMH.F underperformed the US Life Sciences industry which returned 3.4% over the past year.

Return vs Market: SDMH.F underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is SDMH.F's price volatile compared to industry and market?
SDMH.F volatility
SDMH.F Average Weekly Movementn/a
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: SDMH.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SDMH.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
197810,662Rene Faberhttps://www.sartorius.com

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products.

Sartorius Stedim Biotech S.A. Fundamentals Summary

How do Sartorius Stedim Biotech's earnings and revenue compare to its market cap?
SDMH.F fundamental statistics
Market capUS$28.18b
Earnings (TTM)US$335.43m
Revenue (TTM)US$3.01b

84.0x

P/E Ratio

9.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SDMH.F income statement (TTM)
Revenue€2.78b
Cost of Revenue€1.54b
Gross Profit€1.23b
Other Expenses€923.80m
Earnings€309.70m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 18, 2024

Earnings per share (EPS)3.18
Gross Margin44.44%
Net Profit Margin11.16%
Debt/Equity Ratio133.5%

How did SDMH.F perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

21%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.